The predictive value of histological tumor regression grading (TRG) for therapeutic evaluation in locally advanced esophageal carcinoma treated with neoadjuvant chemotherapy.

Chinese Journal of Cancer
Kang GuoLan-Jun Zhang

Abstract

Response criteria remain controversial in therapeutic evaluation for locally advanced esophageal carcinoma treated with neoadjuvant chemotherapy. We aimed to identify the predictive value of tumor regression grading (TRG) in tumor response and prognosis. Fifty-two patients who underwent neoadjuvant chemotherapy followed by esophagectomy and radical 2-field lymphadenectomy between June 2007 and June 2011 were included in this study. All tissue specimens were reassessed according to the TRG scale. Potential prognostic factors, including clinicopathologic factors, were evaluated. Survival curves were generated by using the Kaplan-Meier method and compared with the log-rank test. Prognostic factors were determined with multivariate analysis by using the Cox regression model. Our results showed that of 52 cases, 43 (83%) were squamous cell carcinoma and 9 (17%) were adenocarcinoma. TRG was correlated with pathologic T(P = 0.006) and N (P < 0.001) categories. Median overall survival for the entire cohort was 33 months. The 1- and 2-year overall survival rates were 71% and 44%, respectively. Univariate survival analysis results showed that favorable prognostic factors were histological subtype (P = 0.003), pathologic T category (P = 0...Continue Reading

References

Dec 31, 1998·The New England Journal of Medicine·D P KelsenJ A Roth
Jun 7, 2002·Lancet·UNKNOWN Medical Research Council Oesophageal Cancer Working Group
Jul 18, 2002·The Annals of Thoracic Surgery·John R DotyRichard F Heitmiller
Dec 11, 2002·The Surgical Clinics of North America·Yael Refaely, Mark J Krasna
Jan 7, 2004·American Journal of Surgery·Andreas ImdahlGünther Ruf
Sep 1, 2005·The Lancet Oncology·Bryan H BurmeisterUNKNOWN Australasian Gastro-Intestinal Trials Group
Mar 3, 2007·The Lancet Oncology·Val GebskiUNKNOWN Australasian Gastro-Intestinal Trials Group
Apr 3, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Laurent BedenneChristine Binquet
Jan 1, 2008·International Journal of Radiation Oncology, Biology, Physics·Esther van MeertenMarie-Louise Essink-Bot
Mar 4, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joel TepperRobert Mayer
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Mar 28, 2009·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Tae Jung KimMoon Soo Kim
May 26, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T RuhstallerUNKNOWN Swiss Group for Clinical Cancer Research (SAKK)
Oct 6, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Rupert LangerKaren Becker
Oct 21, 2009·World Journal of Gastroenterology : WJG·Jin LvDong-Dong Wang
Feb 27, 2010·Journal of Surgical Oncology·John R Hyngstrom, Mitchell C Posner
Jun 21, 2011·Clinical Oncology : a Journal of the Royal College of Radiologists·M HingoraniR Roy
Jun 21, 2011·The Lancet Oncology·Katrin M SjoquistUNKNOWN Australasian Gastro-Intestinal Trials Group

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
surgical resection

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.